Crossmark

HS: Empfehlung für IL-17A-Inhibitor

Crossref DOI link: https://doi.org/10.1007/s15012-024-8450-4

Published Online: 2024-05-21

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2024-05-01

Version of Record valid from 2024-05-01
More Information

Article History

First Online: 21 May 2024

Free to read: This content has been made available to all.